Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gallbladder Neoplasms × Crizotinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 5 Neuroblastoma 3 Lymphoma 3 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Large-Cell, Anaplastic 2 Hematologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Large Cell 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 Advanced Cancer 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK or ROS1-positive NSCLC 1

Interventions

Gemcitabine 16 Cisplatin 9 Capecitabine 9 Oxaliplatin 5 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Leucovorin 3 Erlotinib Hydrochloride 3 trifluridine tipiracil drug combination 2 regorafenib 2 Trastuzumab 2 Magnetic Resonance Spectroscopy 2 Bevacizumab 2 zanidatamab 1 vandetanib 1 tucatinib 1 trametinib 1 seribantumab 1 devimistat 1 dehydroftorafur 1 copanlisib 1 cobimetinib 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 Yoga 1 Trifluridine 1 Taxes 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡